nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—CYP2D6—breast cancer	0.0548	0.389	CbGaD
Imipramine—CYP3A4—breast cancer	0.047	0.334	CbGaD
Imipramine—SLC22A3—Melphalan—breast cancer	0.0439	0.136	CbGbCtD
Imipramine—ABCB1—breast cancer	0.0392	0.278	CbGaD
Imipramine—Doxylamine—Toremifene—breast cancer	0.0367	0.12	CrCrCtD
Imipramine—Bromodiphenhydramine—Toremifene—breast cancer	0.031	0.101	CrCrCtD
Imipramine—Clofedanol—Toremifene—breast cancer	0.0252	0.0822	CrCrCtD
Imipramine—Cyclobenzaprine—Tamoxifen—breast cancer	0.0251	0.0818	CrCrCtD
Imipramine—HTR6—Raloxifene—breast cancer	0.0249	0.0773	CbGbCtD
Imipramine—Orphenadrine—Toremifene—breast cancer	0.0244	0.0796	CrCrCtD
Imipramine—Doxylamine—Tamoxifen—breast cancer	0.0231	0.0752	CrCrCtD
Imipramine—Diphenhydramine—Toremifene—breast cancer	0.0217	0.0707	CrCrCtD
Imipramine—Tripelennamine—Tamoxifen—breast cancer	0.0209	0.0681	CrCrCtD
Imipramine—Dimetacrine—Tamoxifen—breast cancer	0.0195	0.0636	CrCrCtD
Imipramine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0195	0.0636	CrCrCtD
Imipramine—Clofedanol—Tamoxifen—breast cancer	0.0158	0.0517	CrCrCtD
Imipramine—Orphenadrine—Tamoxifen—breast cancer	0.0153	0.05	CrCrCtD
Imipramine—SLC22A3—Irinotecan—breast cancer	0.0149	0.046	CbGbCtD
Imipramine—Promazine—Tamoxifen—breast cancer	0.0146	0.0477	CrCrCtD
Imipramine—Diphenhydramine—Tamoxifen—breast cancer	0.0136	0.0444	CrCrCtD
Imipramine—CYP2B6—Thiotepa—breast cancer	0.0135	0.0418	CbGbCtD
Imipramine—CYP1A2—Anastrozole—breast cancer	0.0104	0.0323	CbGbCtD
Imipramine—CYP1A2—Toremifene—breast cancer	0.00954	0.0296	CbGbCtD
Imipramine—CYP2B6—Raloxifene—breast cancer	0.009	0.0279	CbGbCtD
Imipramine—ABCB1—Toremifene—breast cancer	0.00834	0.0259	CbGbCtD
Imipramine—SLC22A2—Vinblastine—breast cancer	0.00782	0.0242	CbGbCtD
Imipramine—CYP2C19—Lapatinib—breast cancer	0.00754	0.0234	CbGbCtD
Imipramine—CYP3A4—Exemestane—breast cancer	0.00721	0.0224	CbGbCtD
Imipramine—CYP2D6—Idarubicin—breast cancer	0.00651	0.0202	CbGbCtD
Imipramine—CYP3A7—Tamoxifen—breast cancer	0.00624	0.0194	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00624	0.0194	CbGbCtD
Imipramine—CYP3A4—Letrozole—breast cancer	0.00613	0.019	CbGbCtD
Imipramine—ABCB1—Lapatinib—breast cancer	0.00609	0.0189	CbGbCtD
Imipramine—CYP2E1—Tamoxifen—breast cancer	0.00603	0.0187	CbGbCtD
Imipramine—CYP2B6—Tamoxifen—breast cancer	0.00595	0.0184	CbGbCtD
Imipramine—CYP2E1—Mitoxantrone—breast cancer	0.00588	0.0182	CbGbCtD
Imipramine—CYP3A4—Anastrozole—breast cancer	0.00547	0.0169	CbGbCtD
Imipramine—CYP3A4—Toremifene—breast cancer	0.005	0.0155	CbGbCtD
Imipramine—CYP3A7—Paclitaxel—breast cancer	0.00486	0.0151	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00486	0.0151	CbGbCtD
Imipramine—CYP3A7—Irinotecan—breast cancer	0.00479	0.0149	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00479	0.0149	CbGbCtD
Imipramine—CYP3A4—Fulvestrant—breast cancer	0.00465	0.0144	CbGbCtD
Imipramine—CYP2B6—Irinotecan—breast cancer	0.00457	0.0141	CbGbCtD
Imipramine—CYP3A4—Thiotepa—breast cancer	0.00414	0.0128	CbGbCtD
Imipramine—CYP3A4—Ixabepilone—breast cancer	0.00379	0.0117	CbGbCtD
Imipramine—CYP2C19—Tamoxifen—breast cancer	0.00378	0.0117	CbGbCtD
Imipramine—CYP3A4—Lapatinib—breast cancer	0.00365	0.0113	CbGbCtD
Imipramine—CYP3A7—Docetaxel—breast cancer	0.00351	0.0109	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00351	0.0109	CbGbCtD
Imipramine—CYP1A2—Tamoxifen—breast cancer	0.00349	0.0108	CbGbCtD
Imipramine—ABCB1—Vinorelbine—breast cancer	0.00338	0.0105	CbGbCtD
Imipramine—CYP2D6—Vinorelbine—breast cancer	0.00318	0.00986	CbGbCtD
Imipramine—ABCB1—Tamoxifen—breast cancer	0.00305	0.00945	CbGbCtD
Imipramine—ABCB1—Mitoxantrone—breast cancer	0.00297	0.00921	CbGbCtD
Imipramine—CYP2D6—Tamoxifen—breast cancer	0.00287	0.0089	CbGbCtD
Imipramine—CYP3A4—Raloxifene—breast cancer	0.00276	0.00857	CbGbCtD
Imipramine—ABCB1—Gemcitabine—breast cancer	0.00263	0.00814	CbGbCtD
Imipramine—CYP1A2—Fluorouracil—breast cancer	0.00257	0.00796	CbGbCtD
Imipramine—CYP2B6—Doxorubicin—breast cancer	0.00249	0.00773	CbGbCtD
Imipramine—ABCB1—Paclitaxel—breast cancer	0.00237	0.00735	CbGbCtD
Imipramine—ABCB1—Irinotecan—breast cancer	0.00234	0.00725	CbGbCtD
Imipramine—ABCB1—Vinblastine—breast cancer	0.00208	0.00645	CbGbCtD
Imipramine—CYP3A4—Vinorelbine—breast cancer	0.00202	0.00627	CbGbCtD
Imipramine—CHRM3—muscle of abdomen—breast cancer	0.00199	0.0836	CbGeAlD
Imipramine—CYP2D6—Vinblastine—breast cancer	0.00196	0.00608	CbGbCtD
Imipramine—CYP3A4—Tamoxifen—breast cancer	0.00183	0.00566	CbGbCtD
Imipramine—CYP3A4—Mitoxantrone—breast cancer	0.00178	0.00552	CbGbCtD
Imipramine—ABCB1—Docetaxel—breast cancer	0.00172	0.00532	CbGbCtD
Imipramine—CYP3A4—Paclitaxel—breast cancer	0.00142	0.00441	CbGbCtD
Imipramine—CYP3A4—Irinotecan—breast cancer	0.0014	0.00435	CbGbCtD
Imipramine—ABCB1—Doxorubicin—breast cancer	0.00128	0.00396	CbGbCtD
Imipramine—CYP3A4—Vinblastine—breast cancer	0.00125	0.00386	CbGbCtD
Imipramine—ABCB1—Methotrexate—breast cancer	0.00124	0.00384	CbGbCtD
Imipramine—CYP2D6—Doxorubicin—breast cancer	0.0012	0.00373	CbGbCtD
Imipramine—CYP3A4—Docetaxel—breast cancer	0.00103	0.00319	CbGbCtD
Imipramine—CYP3A4—Doxorubicin—breast cancer	0.000766	0.00237	CbGbCtD
Imipramine—SLC22A4—mammary gland—breast cancer	0.00054	0.0226	CbGeAlD
Imipramine—KCND2—pituitary gland—breast cancer	0.000531	0.0223	CbGeAlD
Imipramine—KCND2—adipose tissue—breast cancer	0.000529	0.0222	CbGeAlD
Imipramine—KCND3—uterus—breast cancer	0.000471	0.0198	CbGeAlD
Imipramine—KCND3—adipose tissue—breast cancer	0.000461	0.0193	CbGeAlD
Imipramine—KCND2—female gonad—breast cancer	0.000442	0.0185	CbGeAlD
Imipramine—CHRM5—epithelium—breast cancer	0.000425	0.0178	CbGeAlD
Imipramine—KCND3—adrenal gland—breast cancer	0.000414	0.0173	CbGeAlD
Imipramine—SLC22A3—nipple—breast cancer	0.000407	0.017	CbGeAlD
Imipramine—CHRM5—skin of body—breast cancer	0.000404	0.0169	CbGeAlD
Imipramine—ADRA1D—epithelium—breast cancer	0.00038	0.0159	CbGeAlD
Imipramine—SLC22A3—embryo—breast cancer	0.000335	0.0141	CbGeAlD
Imipramine—CYP2C18—endocrine gland—breast cancer	0.000326	0.0137	CbGeAlD
Imipramine—KCNH2—nipple—breast cancer	0.000313	0.0131	CbGeAlD
Imipramine—CYP3A7—endocrine gland—breast cancer	0.000311	0.013	CbGeAlD
Imipramine—ADRA1D—female reproductive system—breast cancer	0.000282	0.0118	CbGeAlD
Imipramine—ORM1—endometrium—breast cancer	0.00028	0.0118	CbGeAlD
Imipramine—SLC22A4—endometrium—breast cancer	0.00027	0.0113	CbGeAlD
Imipramine—CYP1A2—nipple—breast cancer	0.000268	0.0112	CbGeAlD
Imipramine—HRH1—nipple—breast cancer	0.000251	0.0105	CbGeAlD
Imipramine—KCND3—lymph node—breast cancer	0.000248	0.0104	CbGeAlD
Imipramine—SLC22A3—endometrium—breast cancer	0.000245	0.0103	CbGeAlD
Imipramine—SLC22A4—pituitary gland—breast cancer	0.000244	0.0102	CbGeAlD
Imipramine—SLC22A4—adipose tissue—breast cancer	0.000243	0.0102	CbGeAlD
Imipramine—Dimetacrine—ACHE—breast cancer	0.000242	0.102	CrCbGaD
Imipramine—ADRA1D—endocrine gland—breast cancer	0.000239	0.01	CbGeAlD
Imipramine—ORM1—female reproductive system—breast cancer	0.000232	0.00974	CbGeAlD
Imipramine—SLC22A1—adipose tissue—breast cancer	0.000231	0.0097	CbGeAlD
Imipramine—HTR7—epithelium—breast cancer	0.000226	0.00948	CbGeAlD
Imipramine—SLC22A4—female reproductive system—breast cancer	0.000223	0.00937	CbGeAlD
Imipramine—SLC22A3—adipose tissue—breast cancer	0.000221	0.00927	CbGeAlD
Imipramine—ORM1—bone marrow—breast cancer	0.000219	0.00919	CbGeAlD
Imipramine—ADRA1A—epithelium—breast cancer	0.000218	0.00914	CbGeAlD
Imipramine—SLC22A4—adrenal gland—breast cancer	0.000218	0.00914	CbGeAlD
Imipramine—SLC22A4—bone marrow—breast cancer	0.000211	0.00884	CbGeAlD
Imipramine—HTR2C—female reproductive system—breast cancer	0.000209	0.00875	CbGeAlD
Imipramine—SLC22A3—female reproductive system—breast cancer	0.000203	0.00852	CbGeAlD
Imipramine—SLC22A3—adrenal gland—breast cancer	0.000198	0.00832	CbGeAlD
Imipramine—SLC6A4—female reproductive system—breast cancer	0.000198	0.0083	CbGeAlD
Imipramine—CHRM1—female reproductive system—breast cancer	0.000197	0.00826	CbGeAlD
Imipramine—ORM1—endocrine gland—breast cancer	0.000197	0.00824	CbGeAlD
Imipramine—CHRM3—adipose tissue—breast cancer	0.000192	0.00805	CbGeAlD
Imipramine—KCNH2—endometrium—breast cancer	0.000189	0.00792	CbGeAlD
Imipramine—SLC22A3—female gonad—breast cancer	0.000185	0.00776	CbGeAlD
Imipramine—CHRM2—endocrine gland—breast cancer	0.000183	0.00768	CbGeAlD
Imipramine—SLC22A1—endocrine gland—breast cancer	0.00018	0.00755	CbGeAlD
Imipramine—CHRM3—female reproductive system—breast cancer	0.000176	0.0074	CbGeAlD
Imipramine—ADRA1A—adipose tissue—breast cancer	0.000176	0.00739	CbGeAlD
Imipramine—SLC6A2—female reproductive system—breast cancer	0.000174	0.0073	CbGeAlD
Imipramine—KCNH2—uterus—breast cancer	0.000174	0.00729	CbGeAlD
Imipramine—DRD2—pituitary gland—breast cancer	0.000173	0.00727	CbGeAlD
Imipramine—HTR2A—embryo—breast cancer	0.000173	0.00724	CbGeAlD
Imipramine—SLC22A3—endocrine gland—breast cancer	0.000172	0.00721	CbGeAlD
Imipramine—HTR1A—adrenal gland—breast cancer	0.000171	0.00719	CbGeAlD
Imipramine—KCNH2—pituitary gland—breast cancer	0.000171	0.00716	CbGeAlD
Imipramine—SLC6A2—adrenal gland—breast cancer	0.00017	0.00713	CbGeAlD
Imipramine—HRH1—epithelium—breast cancer	0.000169	0.00708	CbGeAlD
Imipramine—HTR7—female reproductive system—breast cancer	0.000168	0.00704	CbGeAlD
Imipramine—SLC6A4—endocrine gland—breast cancer	0.000167	0.00702	CbGeAlD
Imipramine—CHRM1—endocrine gland—breast cancer	0.000167	0.00699	CbGeAlD
Imipramine—CYP2B6—skin of body—breast cancer	0.000164	0.00689	CbGeAlD
Imipramine—HTR7—adrenal gland—breast cancer	0.000164	0.00687	CbGeAlD
Imipramine—CHRM3—female gonad—breast cancer	0.000161	0.00673	CbGeAlD
Imipramine—ADRA1A—adrenal gland—breast cancer	0.000158	0.00663	CbGeAlD
Imipramine—KCNH2—female reproductive system—breast cancer	0.000156	0.00656	CbGeAlD
Imipramine—KCNH2—adrenal gland—breast cancer	0.000153	0.0064	CbGeAlD
Imipramine—HRH1—endometrium—breast cancer	0.000151	0.00634	CbGeAlD
Imipramine—CHRM3—endocrine gland—breast cancer	0.000149	0.00626	CbGeAlD
Imipramine—HTR1A—endocrine gland—breast cancer	0.000149	0.00623	CbGeAlD
Imipramine—KCNH2—bone marrow—breast cancer	0.000148	0.00619	CbGeAlD
Imipramine—SLC6A2—endocrine gland—breast cancer	0.000147	0.00618	CbGeAlD
Imipramine—KCNH2—female gonad—breast cancer	0.000142	0.00597	CbGeAlD
Imipramine—HTR7—endocrine gland—breast cancer	0.000142	0.00596	CbGeAlD
Imipramine—HTR2A—epithelium—breast cancer	0.000141	0.00591	CbGeAlD
Imipramine—CYP2C19—endocrine gland—breast cancer	0.000139	0.00582	CbGeAlD
Imipramine—Benazepril—MTHFR—breast cancer	0.000137	0.0576	CrCbGaD
Imipramine—ADRA1A—endocrine gland—breast cancer	0.000137	0.00575	CbGeAlD
Imipramine—HRH1—adipose tissue—breast cancer	0.000136	0.00572	CbGeAlD
Imipramine—ORM1—lymph node—breast cancer	0.000136	0.0057	CbGeAlD
Imipramine—DRD2—endocrine gland—breast cancer	0.000134	0.00563	CbGeAlD
Imipramine—KCNH2—endocrine gland—breast cancer	0.000132	0.00555	CbGeAlD
Imipramine—SLC22A4—lymph node—breast cancer	0.000131	0.00548	CbGeAlD
Imipramine—CYP2B6—female reproductive system—breast cancer	0.000128	0.00538	CbGeAlD
Imipramine—HRH1—female reproductive system—breast cancer	0.000125	0.00526	CbGeAlD
Imipramine—CYP2B6—adrenal gland—breast cancer	0.000125	0.00525	CbGeAlD
Imipramine—HRH1—adrenal gland—breast cancer	0.000122	0.00513	CbGeAlD
Imipramine—CYP2E1—female reproductive system—breast cancer	0.00012	0.00505	CbGeAlD
Imipramine—SLC22A3—lymph node—breast cancer	0.000119	0.00499	CbGeAlD
Imipramine—CYP2E1—adrenal gland—breast cancer	0.000118	0.00493	CbGeAlD
Imipramine—HTR2A—pituitary gland—breast cancer	0.000114	0.0048	CbGeAlD
Imipramine—HRH1—female gonad—breast cancer	0.000114	0.00478	CbGeAlD
Imipramine—CYP1A2—endocrine gland—breast cancer	0.000113	0.00475	CbGeAlD
Imipramine—ABCB1—embryo—breast cancer	0.000113	0.00475	CbGeAlD
Imipramine—CYP2B6—endocrine gland—breast cancer	0.000109	0.00455	CbGeAlD
Imipramine—HRH1—endocrine gland—breast cancer	0.000106	0.00445	CbGeAlD
Imipramine—HTR2A—female reproductive system—breast cancer	0.000105	0.00439	CbGeAlD
Imipramine—HTR2A—adrenal gland—breast cancer	0.000102	0.00428	CbGeAlD
Imipramine—CYP2E1—endocrine gland—breast cancer	0.000102	0.00427	CbGeAlD
Imipramine—SLC6A2—lymph node—breast cancer	0.000102	0.00427	CbGeAlD
Imipramine—CYP3A4—female reproductive system—breast cancer	9.69e-05	0.00406	CbGeAlD
Imipramine—CYP2D6—female reproductive system—breast cancer	9.54e-05	0.004	CbGeAlD
Imipramine—ABCB1—epithelium—breast cancer	9.24e-05	0.00387	CbGeAlD
Imipramine—KCNH2—lymph node—breast cancer	9.15e-05	0.00384	CbGeAlD
Imipramine—HTR2A—endocrine gland—breast cancer	8.86e-05	0.00371	CbGeAlD
Imipramine—CYP2D6—female gonad—breast cancer	8.68e-05	0.00364	CbGeAlD
Imipramine—Ethopropazine—BCHE—breast cancer	8.47e-05	0.0355	CrCbGaD
Imipramine—ABCB1—endometrium—breast cancer	8.28e-05	0.00347	CbGeAlD
Imipramine—CYP3A4—endocrine gland—breast cancer	8.2e-05	0.00344	CbGeAlD
Imipramine—CYP2D6—endocrine gland—breast cancer	8.07e-05	0.00338	CbGeAlD
Imipramine—ABCB1—uterus—breast cancer	7.63e-05	0.0032	CbGeAlD
Imipramine—ABCB1—pituitary gland—breast cancer	7.5e-05	0.00314	CbGeAlD
Imipramine—ABCB1—adipose tissue—breast cancer	7.47e-05	0.00313	CbGeAlD
Imipramine—Orphenadrine—SCN10A—breast cancer	7.44e-05	0.0312	CrCbGaD
Imipramine—HRH1—lymph node—breast cancer	7.33e-05	0.00307	CbGeAlD
Imipramine—Clomipramine—GSTP1—breast cancer	7.11e-05	0.0298	CrCbGaD
Imipramine—Triflupromazine—BCHE—breast cancer	6.94e-05	0.0291	CrCbGaD
Imipramine—ABCB1—female reproductive system—breast cancer	6.86e-05	0.00288	CbGeAlD
Imipramine—ABCB1—adrenal gland—breast cancer	6.7e-05	0.00281	CbGeAlD
Imipramine—ABCB1—bone marrow—breast cancer	6.48e-05	0.00272	CbGeAlD
Imipramine—ABCB1—female gonad—breast cancer	6.24e-05	0.00262	CbGeAlD
Imipramine—Tripelennamine—CYP2D6—breast cancer	6.13e-05	0.0257	CrCbGaD
Imipramine—Aprindine—CYP2D6—breast cancer	5.99e-05	0.0251	CrCbGaD
Imipramine—ABCB1—endocrine gland—breast cancer	5.81e-05	0.00243	CbGeAlD
Imipramine—Olopatadine—CYP3A4—breast cancer	5.2e-05	0.0218	CrCbGaD
Imipramine—Cyclobenzaprine—CYP2D6—breast cancer	5.1e-05	0.0214	CrCbGaD
Imipramine—Epinastine—CYP2D6—breast cancer	5.06e-05	0.0212	CrCbGaD
Imipramine—Mequitazine—CYP2D6—breast cancer	4.76e-05	0.02	CrCbGaD
Imipramine—Alimemazine—CYP3A4—breast cancer	4.74e-05	0.0199	CrCbGaD
Imipramine—Cyclobenzaprine—CYP3A4—breast cancer	4.37e-05	0.0183	CrCbGaD
Imipramine—Maprotiline—CYP2D6—breast cancer	4.35e-05	0.0183	CrCbGaD
Imipramine—Epinastine—CYP3A4—breast cancer	4.34e-05	0.0182	CrCbGaD
Imipramine—Mequitazine—CYP3A4—breast cancer	4.08e-05	0.0171	CrCbGaD
Imipramine—ABCB1—lymph node—breast cancer	4.01e-05	0.00168	CbGeAlD
Imipramine—Oxcarbazepine—CYP3A4—breast cancer	4e-05	0.0168	CrCbGaD
Imipramine—Nortriptyline—PTGS1—breast cancer	3.84e-05	0.0161	CrCbGaD
Imipramine—Epinastine—ABCB1—breast cancer	3.61e-05	0.0151	CrCbGaD
Imipramine—Diphenhydramine—PTGS1—breast cancer	3.55e-05	0.0149	CrCbGaD
Imipramine—Oxcarbazepine—ALB—breast cancer	3.49e-05	0.0146	CrCbGaD
Imipramine—Pipotiazine—CYP2D6—breast cancer	3.39e-05	0.0142	CrCbGaD
Imipramine—Chlorpromazine—BCHE—breast cancer	3.35e-05	0.014	CrCbGaD
Imipramine—Prochlorperazine—CYP2D6—breast cancer	3.24e-05	0.0136	CrCbGaD
Imipramine—Maprotiline—ABCB1—breast cancer	3.11e-05	0.013	CrCbGaD
Imipramine—Mianserin—CYP2D6—breast cancer	2.93e-05	0.0123	CrCbGaD
Imipramine—Urinary tract disorder—Epirubicin—breast cancer	2.92e-05	0.000242	CcSEcCtD
Imipramine—Urticaria—Paclitaxel—breast cancer	2.92e-05	0.000242	CcSEcCtD
Imipramine—Hyperhidrosis—Capecitabine—breast cancer	2.91e-05	0.000241	CcSEcCtD
Imipramine—Pipotiazine—CYP3A4—breast cancer	2.9e-05	0.0122	CrCbGaD
Imipramine—Abdominal pain—Paclitaxel—breast cancer	2.9e-05	0.000241	CcSEcCtD
Imipramine—Body temperature increased—Paclitaxel—breast cancer	2.9e-05	0.000241	CcSEcCtD
Imipramine—Urethral disorder—Epirubicin—breast cancer	2.9e-05	0.00024	CcSEcCtD
Imipramine—Hepatobiliary disease—Doxorubicin—breast cancer	2.88e-05	0.000239	CcSEcCtD
Imipramine—Anorexia—Capecitabine—breast cancer	2.87e-05	0.000238	CcSEcCtD
Imipramine—Angiopathy—Methotrexate—breast cancer	2.86e-05	0.000237	CcSEcCtD
Imipramine—Vomiting—Irinotecan—breast cancer	2.86e-05	0.000237	CcSEcCtD
Imipramine—Vomiting—Mitoxantrone—breast cancer	2.86e-05	0.000237	CcSEcCtD
Imipramine—Immune system disorder—Methotrexate—breast cancer	2.85e-05	0.000236	CcSEcCtD
Imipramine—Dizziness—Fluorouracil—breast cancer	2.85e-05	0.000236	CcSEcCtD
Imipramine—Mediastinal disorder—Methotrexate—breast cancer	2.85e-05	0.000236	CcSEcCtD
Imipramine—Agranulocytosis—Doxorubicin—breast cancer	2.84e-05	0.000236	CcSEcCtD
Imipramine—Rash—Irinotecan—breast cancer	2.84e-05	0.000235	CcSEcCtD
Imipramine—Rash—Mitoxantrone—breast cancer	2.84e-05	0.000235	CcSEcCtD
Imipramine—Dermatitis—Mitoxantrone—breast cancer	2.84e-05	0.000235	CcSEcCtD
Imipramine—Dermatitis—Irinotecan—breast cancer	2.84e-05	0.000235	CcSEcCtD
Imipramine—Headache—Mitoxantrone—breast cancer	2.82e-05	0.000234	CcSEcCtD
Imipramine—Headache—Irinotecan—breast cancer	2.82e-05	0.000234	CcSEcCtD
Imipramine—Insomnia—Docetaxel—breast cancer	2.81e-05	0.000233	CcSEcCtD
Imipramine—Paraesthesia—Docetaxel—breast cancer	2.79e-05	0.000232	CcSEcCtD
Imipramine—Alopecia—Methotrexate—breast cancer	2.79e-05	0.000231	CcSEcCtD
Imipramine—Vomiting—Gemcitabine—breast cancer	2.79e-05	0.000231	CcSEcCtD
Imipramine—Prochlorperazine—CYP3A4—breast cancer	2.78e-05	0.0116	CrCbGaD
Imipramine—Somnolence—Docetaxel—breast cancer	2.77e-05	0.000229	CcSEcCtD
Imipramine—Mental disorder—Methotrexate—breast cancer	2.77e-05	0.000229	CcSEcCtD
Imipramine—Rash—Gemcitabine—breast cancer	2.76e-05	0.000229	CcSEcCtD
Imipramine—Dermatitis—Gemcitabine—breast cancer	2.76e-05	0.000229	CcSEcCtD
Imipramine—Eye disorder—Epirubicin—breast cancer	2.76e-05	0.000229	CcSEcCtD
Imipramine—Tinnitus—Epirubicin—breast cancer	2.75e-05	0.000228	CcSEcCtD
Imipramine—Malnutrition—Methotrexate—breast cancer	2.75e-05	0.000228	CcSEcCtD
Imipramine—Headache—Gemcitabine—breast cancer	2.75e-05	0.000228	CcSEcCtD
Imipramine—Cardiac disorder—Epirubicin—breast cancer	2.74e-05	0.000227	CcSEcCtD
Imipramine—Flushing—Epirubicin—breast cancer	2.74e-05	0.000227	CcSEcCtD
Imipramine—Vomiting—Fluorouracil—breast cancer	2.74e-05	0.000227	CcSEcCtD
Imipramine—Dyspepsia—Docetaxel—breast cancer	2.74e-05	0.000227	CcSEcCtD
Imipramine—Hepatitis—Doxorubicin—breast cancer	2.73e-05	0.000227	CcSEcCtD
Imipramine—Insomnia—Capecitabine—breast cancer	2.73e-05	0.000226	CcSEcCtD
Imipramine—Carbamazepine—CYP3A4—breast cancer	2.72e-05	0.0114	CrCbGaD
Imipramine—Hypoaesthesia—Doxorubicin—breast cancer	2.72e-05	0.000225	CcSEcCtD
Imipramine—Rash—Fluorouracil—breast cancer	2.72e-05	0.000225	CcSEcCtD
Imipramine—Triflupromazine—ABCB1—breast cancer	2.72e-05	0.0114	CrCbGaD
Imipramine—Dermatitis—Fluorouracil—breast cancer	2.72e-05	0.000225	CcSEcCtD
Imipramine—Paraesthesia—Capecitabine—breast cancer	2.71e-05	0.000224	CcSEcCtD
Imipramine—Decreased appetite—Docetaxel—breast cancer	2.71e-05	0.000224	CcSEcCtD
Imipramine—Headache—Fluorouracil—breast cancer	2.7e-05	0.000224	CcSEcCtD
Imipramine—Urinary tract disorder—Doxorubicin—breast cancer	2.7e-05	0.000224	CcSEcCtD
Imipramine—Dysgeusia—Methotrexate—breast cancer	2.69e-05	0.000223	CcSEcCtD
Imipramine—Gastrointestinal disorder—Docetaxel—breast cancer	2.69e-05	0.000223	CcSEcCtD
Imipramine—Fatigue—Docetaxel—breast cancer	2.68e-05	0.000222	CcSEcCtD
Imipramine—Angiopathy—Epirubicin—breast cancer	2.68e-05	0.000222	CcSEcCtD
Imipramine—Urethral disorder—Doxorubicin—breast cancer	2.68e-05	0.000222	CcSEcCtD
Imipramine—Clomipramine—CYP2D6—breast cancer	2.68e-05	0.0112	CrCbGaD
Imipramine—Nausea—Irinotecan—breast cancer	2.67e-05	0.000222	CcSEcCtD
Imipramine—Nausea—Mitoxantrone—breast cancer	2.67e-05	0.000222	CcSEcCtD
Imipramine—Immune system disorder—Epirubicin—breast cancer	2.67e-05	0.000221	CcSEcCtD
Imipramine—Mediastinal disorder—Epirubicin—breast cancer	2.66e-05	0.000221	CcSEcCtD
Imipramine—Constipation—Docetaxel—breast cancer	2.66e-05	0.000221	CcSEcCtD
Imipramine—Dyspepsia—Capecitabine—breast cancer	2.65e-05	0.00022	CcSEcCtD
Imipramine—Arrhythmia—Epirubicin—breast cancer	2.64e-05	0.000219	CcSEcCtD
Imipramine—Acepromazine—ALB—breast cancer	2.64e-05	0.011	CrCbGaD
Imipramine—Asthenia—Paclitaxel—breast cancer	2.63e-05	0.000218	CcSEcCtD
Imipramine—Decreased appetite—Capecitabine—breast cancer	2.62e-05	0.000217	CcSEcCtD
Imipramine—Nortriptyline—CYP2D6—breast cancer	2.62e-05	0.011	CrCbGaD
Imipramine—Alopecia—Epirubicin—breast cancer	2.61e-05	0.000216	CcSEcCtD
Imipramine—Nausea—Gemcitabine—breast cancer	2.6e-05	0.000216	CcSEcCtD
Imipramine—Gastrointestinal disorder—Capecitabine—breast cancer	2.6e-05	0.000216	CcSEcCtD
Imipramine—Fatigue—Capecitabine—breast cancer	2.6e-05	0.000215	CcSEcCtD
Imipramine—Pruritus—Paclitaxel—breast cancer	2.6e-05	0.000215	CcSEcCtD
Imipramine—Vision blurred—Methotrexate—breast cancer	2.59e-05	0.000215	CcSEcCtD
Imipramine—Mental disorder—Epirubicin—breast cancer	2.59e-05	0.000215	CcSEcCtD
Imipramine—Constipation—Capecitabine—breast cancer	2.58e-05	0.000214	CcSEcCtD
Imipramine—Thioproperazine—ALB—breast cancer	2.58e-05	0.0108	CrCbGaD
Imipramine—Malnutrition—Epirubicin—breast cancer	2.57e-05	0.000213	CcSEcCtD
Imipramine—Feeling abnormal—Docetaxel—breast cancer	2.56e-05	0.000213	CcSEcCtD
Imipramine—Nausea—Fluorouracil—breast cancer	2.56e-05	0.000212	CcSEcCtD
Imipramine—Eye disorder—Doxorubicin—breast cancer	2.55e-05	0.000212	CcSEcCtD
Imipramine—Ill-defined disorder—Methotrexate—breast cancer	2.55e-05	0.000211	CcSEcCtD
Imipramine—Tinnitus—Doxorubicin—breast cancer	2.55e-05	0.000211	CcSEcCtD
Imipramine—Gastrointestinal pain—Docetaxel—breast cancer	2.54e-05	0.000211	CcSEcCtD
Imipramine—Flushing—Doxorubicin—breast cancer	2.54e-05	0.00021	CcSEcCtD
Imipramine—Cardiac disorder—Doxorubicin—breast cancer	2.54e-05	0.00021	CcSEcCtD
Imipramine—Pipotiazine—ALB—breast cancer	2.53e-05	0.0106	CrCbGaD
Imipramine—Tension—Epirubicin—breast cancer	2.52e-05	0.000209	CcSEcCtD
Imipramine—Dysgeusia—Epirubicin—breast cancer	2.52e-05	0.000209	CcSEcCtD
Imipramine—Diarrhoea—Paclitaxel—breast cancer	2.51e-05	0.000208	CcSEcCtD
Imipramine—Mianserin—CYP3A4—breast cancer	2.51e-05	0.0105	CrCbGaD
Imipramine—Nervousness—Epirubicin—breast cancer	2.5e-05	0.000207	CcSEcCtD
Imipramine—Feeling abnormal—Capecitabine—breast cancer	2.48e-05	0.000206	CcSEcCtD
Imipramine—Angiopathy—Doxorubicin—breast cancer	2.48e-05	0.000206	CcSEcCtD
Imipramine—Malaise—Methotrexate—breast cancer	2.48e-05	0.000205	CcSEcCtD
Imipramine—Immune system disorder—Doxorubicin—breast cancer	2.47e-05	0.000205	CcSEcCtD
Imipramine—Gastrointestinal pain—Capecitabine—breast cancer	2.46e-05	0.000204	CcSEcCtD
Imipramine—Mediastinal disorder—Doxorubicin—breast cancer	2.46e-05	0.000204	CcSEcCtD
Imipramine—Trimipramine—CYP2D6—breast cancer	2.46e-05	0.0103	CrCbGaD
Imipramine—Body temperature increased—Docetaxel—breast cancer	2.46e-05	0.000204	CcSEcCtD
Imipramine—Abdominal pain—Docetaxel—breast cancer	2.46e-05	0.000204	CcSEcCtD
Imipramine—Leukopenia—Methotrexate—breast cancer	2.46e-05	0.000204	CcSEcCtD
Imipramine—Arrhythmia—Doxorubicin—breast cancer	2.44e-05	0.000202	CcSEcCtD
Imipramine—Dizziness—Paclitaxel—breast cancer	2.43e-05	0.000201	CcSEcCtD
Imipramine—Vision blurred—Epirubicin—breast cancer	2.42e-05	0.000201	CcSEcCtD
Imipramine—Diphenhydramine—CYP2D6—breast cancer	2.42e-05	0.0101	CrCbGaD
Imipramine—Alopecia—Doxorubicin—breast cancer	2.42e-05	0.0002	CcSEcCtD
Imipramine—Methotrimeprazine—CYP2D6—breast cancer	2.41e-05	0.0101	CrCbGaD
Imipramine—Mental disorder—Doxorubicin—breast cancer	2.39e-05	0.000199	CcSEcCtD
Imipramine—Urticaria—Capecitabine—breast cancer	2.39e-05	0.000198	CcSEcCtD
Imipramine—Ill-defined disorder—Epirubicin—breast cancer	2.39e-05	0.000198	CcSEcCtD
Imipramine—Abdominal pain—Capecitabine—breast cancer	2.38e-05	0.000197	CcSEcCtD
Imipramine—Body temperature increased—Capecitabine—breast cancer	2.38e-05	0.000197	CcSEcCtD
Imipramine—Convulsion—Methotrexate—breast cancer	2.38e-05	0.000197	CcSEcCtD
Imipramine—Malnutrition—Doxorubicin—breast cancer	2.38e-05	0.000197	CcSEcCtD
Imipramine—Promethazine—CYP2D6—breast cancer	2.37e-05	0.00994	CrCbGaD
Imipramine—Agitation—Epirubicin—breast cancer	2.36e-05	0.000196	CcSEcCtD
Imipramine—Doxepin—CYP2D6—breast cancer	2.35e-05	0.00984	CrCbGaD
Imipramine—Tension—Doxorubicin—breast cancer	2.34e-05	0.000194	CcSEcCtD
Imipramine—Vomiting—Paclitaxel—breast cancer	2.33e-05	0.000194	CcSEcCtD
Imipramine—Dysgeusia—Doxorubicin—breast cancer	2.33e-05	0.000193	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.32e-05	0.000193	CcSEcCtD
Imipramine—Malaise—Epirubicin—breast cancer	2.32e-05	0.000192	CcSEcCtD
Imipramine—Rash—Paclitaxel—breast cancer	2.31e-05	0.000192	CcSEcCtD
Imipramine—Dermatitis—Paclitaxel—breast cancer	2.31e-05	0.000192	CcSEcCtD
Imipramine—Discomfort—Methotrexate—breast cancer	2.31e-05	0.000192	CcSEcCtD
Imipramine—Nervousness—Doxorubicin—breast cancer	2.31e-05	0.000192	CcSEcCtD
Imipramine—Syncope—Epirubicin—breast cancer	2.31e-05	0.000191	CcSEcCtD
Imipramine—Leukopenia—Epirubicin—breast cancer	2.3e-05	0.000191	CcSEcCtD
Imipramine—Headache—Paclitaxel—breast cancer	2.3e-05	0.000191	CcSEcCtD
Imipramine—Clomipramine—CYP3A4—breast cancer	2.3e-05	0.00962	CrCbGaD
Imipramine—Palpitations—Epirubicin—breast cancer	2.27e-05	0.000188	CcSEcCtD
Imipramine—Carbamazepine—ABCB1—breast cancer	2.27e-05	0.00951	CrCbGaD
Imipramine—Confusional state—Methotrexate—breast cancer	2.26e-05	0.000187	CcSEcCtD
Imipramine—Loss of consciousness—Epirubicin—breast cancer	2.26e-05	0.000187	CcSEcCtD
Imipramine—Nortriptyline—CYP3A4—breast cancer	2.24e-05	0.0094	CrCbGaD
Imipramine—Anaphylactic shock—Methotrexate—breast cancer	2.24e-05	0.000186	CcSEcCtD
Imipramine—Vision blurred—Doxorubicin—breast cancer	2.24e-05	0.000186	CcSEcCtD
Imipramine—Asthenia—Docetaxel—breast cancer	2.23e-05	0.000185	CcSEcCtD
Imipramine—Convulsion—Epirubicin—breast cancer	2.23e-05	0.000185	CcSEcCtD
Imipramine—Infection—Methotrexate—breast cancer	2.23e-05	0.000185	CcSEcCtD
Imipramine—Hypertension—Epirubicin—breast cancer	2.22e-05	0.000184	CcSEcCtD
Imipramine—Ill-defined disorder—Doxorubicin—breast cancer	2.21e-05	0.000183	CcSEcCtD
Imipramine—Pruritus—Docetaxel—breast cancer	2.2e-05	0.000183	CcSEcCtD
Imipramine—Nervous system disorder—Methotrexate—breast cancer	2.2e-05	0.000182	CcSEcCtD
Imipramine—Thrombocytopenia—Methotrexate—breast cancer	2.2e-05	0.000182	CcSEcCtD
Imipramine—Agitation—Doxorubicin—breast cancer	2.19e-05	0.000181	CcSEcCtD
Imipramine—Anxiety—Epirubicin—breast cancer	2.18e-05	0.000181	CcSEcCtD
Imipramine—Nausea—Paclitaxel—breast cancer	2.18e-05	0.000181	CcSEcCtD
Imipramine—Skin disorder—Methotrexate—breast cancer	2.18e-05	0.000181	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.17e-05	0.00018	CcSEcCtD
Imipramine—Hyperhidrosis—Methotrexate—breast cancer	2.17e-05	0.00018	CcSEcCtD
Imipramine—Discomfort—Epirubicin—breast cancer	2.16e-05	0.000179	CcSEcCtD
Imipramine—Asthenia—Capecitabine—breast cancer	2.16e-05	0.000179	CcSEcCtD
Imipramine—Desipramine—CYP2D6—breast cancer	2.15e-05	0.00903	CrCbGaD
Imipramine—Malaise—Doxorubicin—breast cancer	2.15e-05	0.000178	CcSEcCtD
Imipramine—Dry mouth—Epirubicin—breast cancer	2.14e-05	0.000178	CcSEcCtD
Imipramine—Anorexia—Methotrexate—breast cancer	2.14e-05	0.000177	CcSEcCtD
Imipramine—Syncope—Doxorubicin—breast cancer	2.13e-05	0.000177	CcSEcCtD
Imipramine—Pruritus—Capecitabine—breast cancer	2.13e-05	0.000177	CcSEcCtD
Imipramine—Leukopenia—Doxorubicin—breast cancer	2.13e-05	0.000177	CcSEcCtD
Imipramine—Diarrhoea—Docetaxel—breast cancer	2.13e-05	0.000177	CcSEcCtD
Imipramine—Confusional state—Epirubicin—breast cancer	2.12e-05	0.000175	CcSEcCtD
Imipramine—Trimipramine—CYP3A4—breast cancer	2.11e-05	0.00885	CrCbGaD
Imipramine—Palpitations—Doxorubicin—breast cancer	2.1e-05	0.000174	CcSEcCtD
Imipramine—Anaphylactic shock—Epirubicin—breast cancer	2.1e-05	0.000174	CcSEcCtD
Imipramine—Oedema—Epirubicin—breast cancer	2.1e-05	0.000174	CcSEcCtD
Imipramine—Loss of consciousness—Doxorubicin—breast cancer	2.09e-05	0.000173	CcSEcCtD
Imipramine—Infection—Epirubicin—breast cancer	2.09e-05	0.000173	CcSEcCtD
Imipramine—Shock—Epirubicin—breast cancer	2.07e-05	0.000171	CcSEcCtD
Imipramine—Convulsion—Doxorubicin—breast cancer	2.06e-05	0.000171	CcSEcCtD
Imipramine—Diarrhoea—Capecitabine—breast cancer	2.06e-05	0.000171	CcSEcCtD
Imipramine—Nervous system disorder—Epirubicin—breast cancer	2.06e-05	0.000171	CcSEcCtD
Imipramine—Dizziness—Docetaxel—breast cancer	2.06e-05	0.000171	CcSEcCtD
Imipramine—Thrombocytopenia—Epirubicin—breast cancer	2.06e-05	0.00017	CcSEcCtD
Imipramine—Hypertension—Doxorubicin—breast cancer	2.05e-05	0.00017	CcSEcCtD
Imipramine—Tachycardia—Epirubicin—breast cancer	2.05e-05	0.00017	CcSEcCtD
Imipramine—Skin disorder—Epirubicin—breast cancer	2.04e-05	0.000169	CcSEcCtD
Imipramine—Hyperhidrosis—Epirubicin—breast cancer	2.03e-05	0.000168	CcSEcCtD
Imipramine—Insomnia—Methotrexate—breast cancer	2.03e-05	0.000168	CcSEcCtD
Imipramine—Anxiety—Doxorubicin—breast cancer	2.02e-05	0.000167	CcSEcCtD
Imipramine—Paraesthesia—Methotrexate—breast cancer	2.01e-05	0.000167	CcSEcCtD
Imipramine—Doxepin—CYP3A4—breast cancer	2.01e-05	0.00844	CrCbGaD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.01e-05	0.000167	CcSEcCtD
Imipramine—Clomipramine—ALB—breast cancer	2e-05	0.00839	CrCbGaD
Imipramine—Discomfort—Doxorubicin—breast cancer	2e-05	0.000166	CcSEcCtD
Imipramine—Anorexia—Epirubicin—breast cancer	2e-05	0.000166	CcSEcCtD
Imipramine—Somnolence—Methotrexate—breast cancer	1.99e-05	0.000165	CcSEcCtD
Imipramine—Dizziness—Capecitabine—breast cancer	1.99e-05	0.000165	CcSEcCtD
Imipramine—Dry mouth—Doxorubicin—breast cancer	1.98e-05	0.000164	CcSEcCtD
Imipramine—Vomiting—Docetaxel—breast cancer	1.98e-05	0.000164	CcSEcCtD
Imipramine—Dyspepsia—Methotrexate—breast cancer	1.97e-05	0.000164	CcSEcCtD
Imipramine—Orphenadrine—CYP3A4—breast cancer	1.96e-05	0.00822	CrCbGaD
Imipramine—Rash—Docetaxel—breast cancer	1.96e-05	0.000163	CcSEcCtD
Imipramine—Dermatitis—Docetaxel—breast cancer	1.96e-05	0.000163	CcSEcCtD
Imipramine—Confusional state—Doxorubicin—breast cancer	1.96e-05	0.000162	CcSEcCtD
Imipramine—Nortriptyline—ALB—breast cancer	1.96e-05	0.0082	CrCbGaD
Imipramine—Decreased appetite—Methotrexate—breast cancer	1.95e-05	0.000162	CcSEcCtD
Imipramine—Headache—Docetaxel—breast cancer	1.95e-05	0.000162	CcSEcCtD
Imipramine—Oedema—Doxorubicin—breast cancer	1.94e-05	0.000161	CcSEcCtD
Imipramine—Anaphylactic shock—Doxorubicin—breast cancer	1.94e-05	0.000161	CcSEcCtD
Imipramine—Gastrointestinal disorder—Methotrexate—breast cancer	1.94e-05	0.000161	CcSEcCtD
Imipramine—Fatigue—Methotrexate—breast cancer	1.93e-05	0.00016	CcSEcCtD
Imipramine—Infection—Doxorubicin—breast cancer	1.93e-05	0.00016	CcSEcCtD
Imipramine—Vomiting—Capecitabine—breast cancer	1.92e-05	0.000159	CcSEcCtD
Imipramine—Clomipramine—ABCB1—breast cancer	1.91e-05	0.00801	CrCbGaD
Imipramine—Shock—Doxorubicin—breast cancer	1.91e-05	0.000158	CcSEcCtD
Imipramine—Nervous system disorder—Doxorubicin—breast cancer	1.9e-05	0.000158	CcSEcCtD
Imipramine—Thrombocytopenia—Doxorubicin—breast cancer	1.9e-05	0.000158	CcSEcCtD
Imipramine—Rash—Capecitabine—breast cancer	1.9e-05	0.000157	CcSEcCtD
Imipramine—Insomnia—Epirubicin—breast cancer	1.9e-05	0.000157	CcSEcCtD
Imipramine—Dermatitis—Capecitabine—breast cancer	1.9e-05	0.000157	CcSEcCtD
Imipramine—Tachycardia—Doxorubicin—breast cancer	1.9e-05	0.000157	CcSEcCtD
Imipramine—Headache—Capecitabine—breast cancer	1.89e-05	0.000156	CcSEcCtD
Imipramine—Skin disorder—Doxorubicin—breast cancer	1.89e-05	0.000156	CcSEcCtD
Imipramine—Paraesthesia—Epirubicin—breast cancer	1.88e-05	0.000156	CcSEcCtD
Imipramine—Hyperhidrosis—Doxorubicin—breast cancer	1.88e-05	0.000156	CcSEcCtD
Imipramine—Somnolence—Epirubicin—breast cancer	1.87e-05	0.000155	CcSEcCtD
Imipramine—Anorexia—Doxorubicin—breast cancer	1.85e-05	0.000153	CcSEcCtD
Imipramine—Nausea—Docetaxel—breast cancer	1.85e-05	0.000153	CcSEcCtD
Imipramine—Feeling abnormal—Methotrexate—breast cancer	1.85e-05	0.000153	CcSEcCtD
Imipramine—Dyspepsia—Epirubicin—breast cancer	1.85e-05	0.000153	CcSEcCtD
Imipramine—Desipramine—CYP3A4—breast cancer	1.85e-05	0.00774	CrCbGaD
Imipramine—Chlorpromazine—CYP2D6—breast cancer	1.84e-05	0.0077	CrCbGaD
Imipramine—Gastrointestinal pain—Methotrexate—breast cancer	1.83e-05	0.000152	CcSEcCtD
Imipramine—Decreased appetite—Epirubicin—breast cancer	1.82e-05	0.000151	CcSEcCtD
Imipramine—Amitriptyline—CYP2D6—breast cancer	1.82e-05	0.00761	CrCbGaD
Imipramine—Gastrointestinal disorder—Epirubicin—breast cancer	1.81e-05	0.00015	CcSEcCtD
Imipramine—Fatigue—Epirubicin—breast cancer	1.81e-05	0.00015	CcSEcCtD
Imipramine—Constipation—Epirubicin—breast cancer	1.79e-05	0.000149	CcSEcCtD
Imipramine—Nausea—Capecitabine—breast cancer	1.79e-05	0.000148	CcSEcCtD
Imipramine—Promazine—CYP3A4—breast cancer	1.79e-05	0.0075	CrCbGaD
Imipramine—Urticaria—Methotrexate—breast cancer	1.78e-05	0.000148	CcSEcCtD
Imipramine—Abdominal pain—Methotrexate—breast cancer	1.77e-05	0.000147	CcSEcCtD
Imipramine—Body temperature increased—Methotrexate—breast cancer	1.77e-05	0.000147	CcSEcCtD
Imipramine—Trimipramine—ABCB1—breast cancer	1.76e-05	0.00737	CrCbGaD
Imipramine—Insomnia—Doxorubicin—breast cancer	1.76e-05	0.000146	CcSEcCtD
Imipramine—Paraesthesia—Doxorubicin—breast cancer	1.74e-05	0.000145	CcSEcCtD
Imipramine—Feeling abnormal—Epirubicin—breast cancer	1.73e-05	0.000143	CcSEcCtD
Imipramine—Somnolence—Doxorubicin—breast cancer	1.73e-05	0.000143	CcSEcCtD
Imipramine—Gastrointestinal pain—Epirubicin—breast cancer	1.72e-05	0.000142	CcSEcCtD
Imipramine—Dyspepsia—Doxorubicin—breast cancer	1.71e-05	0.000142	CcSEcCtD
Imipramine—Promethazine—ABCB1—breast cancer	1.69e-05	0.0071	CrCbGaD
Imipramine—Decreased appetite—Doxorubicin—breast cancer	1.69e-05	0.00014	CcSEcCtD
Imipramine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.68e-05	0.000139	CcSEcCtD
Imipramine—Doxepin—ABCB1—breast cancer	1.68e-05	0.00702	CrCbGaD
Imipramine—Fatigue—Doxorubicin—breast cancer	1.67e-05	0.000139	CcSEcCtD
Imipramine—Urticaria—Epirubicin—breast cancer	1.67e-05	0.000138	CcSEcCtD
Imipramine—Constipation—Doxorubicin—breast cancer	1.66e-05	0.000138	CcSEcCtD
Imipramine—Body temperature increased—Epirubicin—breast cancer	1.66e-05	0.000138	CcSEcCtD
Imipramine—Abdominal pain—Epirubicin—breast cancer	1.66e-05	0.000138	CcSEcCtD
Imipramine—Asthenia—Methotrexate—breast cancer	1.61e-05	0.000133	CcSEcCtD
Imipramine—Feeling abnormal—Doxorubicin—breast cancer	1.6e-05	0.000133	CcSEcCtD
Imipramine—Gastrointestinal pain—Doxorubicin—breast cancer	1.59e-05	0.000132	CcSEcCtD
Imipramine—Pruritus—Methotrexate—breast cancer	1.59e-05	0.000132	CcSEcCtD
Imipramine—Chlorpromazine—CYP3A4—breast cancer	1.57e-05	0.0066	CrCbGaD
Imipramine—Amitriptyline—CYP3A4—breast cancer	1.56e-05	0.00653	CrCbGaD
Imipramine—Urticaria—Doxorubicin—breast cancer	1.54e-05	0.000128	CcSEcCtD
Imipramine—Desipramine—ABCB1—breast cancer	1.54e-05	0.00645	CrCbGaD
Imipramine—Body temperature increased—Doxorubicin—breast cancer	1.54e-05	0.000127	CcSEcCtD
Imipramine—Abdominal pain—Doxorubicin—breast cancer	1.54e-05	0.000127	CcSEcCtD
Imipramine—Diarrhoea—Methotrexate—breast cancer	1.53e-05	0.000127	CcSEcCtD
Imipramine—Asthenia—Epirubicin—breast cancer	1.51e-05	0.000125	CcSEcCtD
Imipramine—Pruritus—Epirubicin—breast cancer	1.48e-05	0.000123	CcSEcCtD
Imipramine—Dizziness—Methotrexate—breast cancer	1.48e-05	0.000123	CcSEcCtD
Imipramine—Diarrhoea—Epirubicin—breast cancer	1.44e-05	0.000119	CcSEcCtD
Imipramine—Vomiting—Methotrexate—breast cancer	1.43e-05	0.000118	CcSEcCtD
Imipramine—Rash—Methotrexate—breast cancer	1.41e-05	0.000117	CcSEcCtD
Imipramine—Dermatitis—Methotrexate—breast cancer	1.41e-05	0.000117	CcSEcCtD
Imipramine—Headache—Methotrexate—breast cancer	1.41e-05	0.000116	CcSEcCtD
Imipramine—Asthenia—Doxorubicin—breast cancer	1.39e-05	0.000116	CcSEcCtD
Imipramine—Dizziness—Epirubicin—breast cancer	1.39e-05	0.000115	CcSEcCtD
Imipramine—Pruritus—Doxorubicin—breast cancer	1.37e-05	0.000114	CcSEcCtD
Imipramine—Chlorpromazine—ALB—breast cancer	1.37e-05	0.00576	CrCbGaD
Imipramine—Amitriptyline—ALB—breast cancer	1.36e-05	0.00569	CrCbGaD
Imipramine—Vomiting—Epirubicin—breast cancer	1.33e-05	0.000111	CcSEcCtD
Imipramine—Nausea—Methotrexate—breast cancer	1.33e-05	0.00011	CcSEcCtD
Imipramine—Diarrhoea—Doxorubicin—breast cancer	1.33e-05	0.00011	CcSEcCtD
Imipramine—Rash—Epirubicin—breast cancer	1.32e-05	0.00011	CcSEcCtD
Imipramine—Dermatitis—Epirubicin—breast cancer	1.32e-05	0.00011	CcSEcCtD
Imipramine—Headache—Epirubicin—breast cancer	1.31e-05	0.000109	CcSEcCtD
Imipramine—Chlorpromazine—ABCB1—breast cancer	1.31e-05	0.00549	CrCbGaD
Imipramine—Amitriptyline—ABCB1—breast cancer	1.3e-05	0.00543	CrCbGaD
Imipramine—Dizziness—Doxorubicin—breast cancer	1.28e-05	0.000106	CcSEcCtD
Imipramine—Nausea—Epirubicin—breast cancer	1.25e-05	0.000103	CcSEcCtD
Imipramine—Vomiting—Doxorubicin—breast cancer	1.23e-05	0.000102	CcSEcCtD
Imipramine—Rash—Doxorubicin—breast cancer	1.22e-05	0.000102	CcSEcCtD
Imipramine—Dermatitis—Doxorubicin—breast cancer	1.22e-05	0.000101	CcSEcCtD
Imipramine—Headache—Doxorubicin—breast cancer	1.22e-05	0.000101	CcSEcCtD
Imipramine—Nausea—Doxorubicin—breast cancer	1.15e-05	9.56e-05	CcSEcCtD
Imipramine—DRD2—Signaling Pathways—CDKN1A—breast cancer	6.87e-07	8.29e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCND1—breast cancer	6.86e-07	8.27e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CTNNB1—breast cancer	6.86e-07	8.27e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PTEN—breast cancer	6.86e-07	8.27e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—JUN—breast cancer	6.85e-07	8.26e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCND1—breast cancer	6.84e-07	8.25e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—JUN—breast cancer	6.83e-07	8.23e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—HMOX1—breast cancer	6.83e-07	8.23e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—breast cancer	6.81e-07	8.22e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ITPR1—breast cancer	6.81e-07	8.21e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	6.8e-07	8.19e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—breast cancer	6.79e-07	8.19e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MMP9—breast cancer	6.78e-07	8.18e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	6.78e-07	8.17e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MMP9—breast cancer	6.77e-07	8.16e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	6.76e-07	8.15e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MMP9—breast cancer	6.75e-07	8.14e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN1A—breast cancer	6.75e-07	8.13e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PTEN—breast cancer	6.75e-07	8.13e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTEN—breast cancer	6.74e-07	8.13e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CD—breast cancer	6.74e-07	8.12e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PTEN—breast cancer	6.73e-07	8.12e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MMP9—breast cancer	6.73e-07	8.11e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	6.72e-07	8.11e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—PIK3CA—breast cancer	6.72e-07	8.11e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CAV1—breast cancer	6.72e-07	8.1e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	6.72e-07	8.1e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PTEN—breast cancer	6.71e-07	8.09e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK8—breast cancer	6.71e-07	8.09e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN1A—breast cancer	6.7e-07	8.08e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—breast cancer	6.69e-07	8.06e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PTEN—breast cancer	6.69e-07	8.06e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK3—breast cancer	6.67e-07	8.04e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MMP9—breast cancer	6.66e-07	8.03e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—breast cancer	6.65e-07	8.02e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—STAT3—breast cancer	6.65e-07	8.02e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MMP9—breast cancer	6.64e-07	8.01e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	6.64e-07	8e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK3—breast cancer	6.64e-07	8e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PTEN—breast cancer	6.62e-07	7.99e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	6.62e-07	7.98e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PTEN—breast cancer	6.6e-07	7.96e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK8—breast cancer	6.6e-07	7.96e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—breast cancer	6.59e-07	7.95e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK8—breast cancer	6.58e-07	7.94e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—breast cancer	6.58e-07	7.94e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—breast cancer	6.58e-07	7.94e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—breast cancer	6.57e-07	7.92e-06	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PIK3CA—breast cancer	6.56e-07	7.91e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK8—breast cancer	6.56e-07	7.91e-06	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PIK3CA—breast cancer	6.55e-07	7.9e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCB1—breast cancer	6.55e-07	7.9e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—breast cancer	6.55e-07	7.89e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK8—breast cancer	6.54e-07	7.89e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—breast cancer	6.52e-07	7.87e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—NOS3—breast cancer	6.52e-07	7.86e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—breast cancer	6.5e-07	7.84e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HRAS—breast cancer	6.49e-07	7.83e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—breast cancer	6.49e-07	7.82e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK8—breast cancer	6.48e-07	7.81e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TGFB1—breast cancer	6.47e-07	7.81e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—breast cancer	6.46e-07	7.79e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	6.46e-07	7.79e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—breast cancer	6.46e-07	7.78e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	6.44e-07	7.77e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TGFB1—breast cancer	6.44e-07	7.76e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TYMS—breast cancer	6.43e-07	7.76e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.42e-07	7.74e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—NOS3—breast cancer	6.36e-07	7.67e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PLA2G4A—breast cancer	6.36e-07	7.67e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NCOR1—breast cancer	6.36e-07	7.67e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTM1—breast cancer	6.36e-07	7.67e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SRC—breast cancer	6.36e-07	7.67e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	6.35e-07	7.66e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CD—breast cancer	6.35e-07	7.66e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—breast cancer	6.35e-07	7.65e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	6.32e-07	7.62e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—breast cancer	6.31e-07	7.61e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—breast cancer	6.27e-07	7.56e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SRC—breast cancer	6.26e-07	7.54e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SRC—breast cancer	6.24e-07	7.53e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SRC—breast cancer	6.22e-07	7.5e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HRAS—breast cancer	6.22e-07	7.5e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—breast cancer	6.22e-07	7.5e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SRC—breast cancer	6.2e-07	7.48e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—breast cancer	6.19e-07	7.47e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—breast cancer	6.18e-07	7.45e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	6.16e-07	7.43e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SRC—breast cancer	6.14e-07	7.41e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—STAT3—breast cancer	6.13e-07	7.39e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SRC—breast cancer	6.13e-07	7.39e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CG—breast cancer	6.12e-07	7.38e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—breast cancer	6.11e-07	7.37e-06	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PIK3CA—breast cancer	6.11e-07	7.37e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—breast cancer	6.09e-07	7.35e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GPX1—breast cancer	6.09e-07	7.34e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—breast cancer	6.08e-07	7.33e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—breast cancer	6.08e-07	7.33e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—breast cancer	6.07e-07	7.32e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—breast cancer	6.06e-07	7.31e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—breast cancer	6.04e-07	7.29e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—breast cancer	6.04e-07	7.28e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—STAT3—breast cancer	6.03e-07	7.27e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP1A1—breast cancer	6.03e-07	7.27e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—STAT3—breast cancer	6.02e-07	7.26e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CB—breast cancer	6.02e-07	7.26e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—STAT3—breast cancer	6e-07	7.24e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—NOS3—breast cancer	6e-07	7.23e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—KRAS—breast cancer	6e-07	7.23e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—breast cancer	5.98e-07	7.21e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—STAT3—breast cancer	5.98e-07	7.21e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ERCC2—breast cancer	5.98e-07	7.21e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	5.97e-07	7.19e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—KRAS—breast cancer	5.96e-07	7.19e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—breast cancer	5.96e-07	7.19e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—breast cancer	5.95e-07	7.18e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—STAT3—breast cancer	5.92e-07	7.14e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—STAT3—breast cancer	5.91e-07	7.12e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CB—breast cancer	5.87e-07	7.08e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK3—breast cancer	5.86e-07	7.06e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HRAS—breast cancer	5.85e-07	7.05e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—breast cancer	5.82e-07	7.02e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK3—breast cancer	5.76e-07	6.95e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK3—breast cancer	5.75e-07	6.93e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—breast cancer	5.73e-07	6.91e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK3—breast cancer	5.73e-07	6.91e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK3—breast cancer	5.71e-07	6.89e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—KRAS—breast cancer	5.71e-07	6.88e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—breast cancer	5.7e-07	6.87e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TGFB1—breast cancer	5.68e-07	6.85e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK3—breast cancer	5.66e-07	6.82e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	5.64e-07	6.8e-06	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PIK3CA—breast cancer	5.64e-07	6.8e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MTHFR—breast cancer	5.62e-07	6.78e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—breast cancer	5.61e-07	6.76e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—breast cancer	5.6e-07	6.75e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—breast cancer	5.59e-07	6.74e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TGFB1—breast cancer	5.59e-07	6.74e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TGFB1—breast cancer	5.58e-07	6.73e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—breast cancer	5.58e-07	6.72e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—breast cancer	5.57e-07	6.72e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TGFB1—breast cancer	5.56e-07	6.71e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—breast cancer	5.56e-07	6.7e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TGFB1—breast cancer	5.54e-07	6.69e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CB—breast cancer	5.53e-07	6.67e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	5.51e-07	6.64e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—breast cancer	5.5e-07	6.64e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—breast cancer	5.49e-07	6.62e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TGFB1—breast cancer	5.49e-07	6.62e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—breast cancer	5.49e-07	6.62e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—breast cancer	5.48e-07	6.61e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—breast cancer	5.48e-07	6.61e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	5.48e-07	6.61e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	5.48e-07	6.6e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—breast cancer	5.47e-07	6.6e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—breast cancer	5.45e-07	6.58e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—breast cancer	5.44e-07	6.56e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—breast cancer	5.38e-07	6.49e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CD—breast cancer	5.38e-07	6.49e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—breast cancer	5.37e-07	6.47e-06	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—breast cancer	5.36e-07	6.47e-06	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—breast cancer	5.35e-07	6.46e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—breast cancer	5.33e-07	6.43e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—breast cancer	5.31e-07	6.4e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—breast cancer	5.3e-07	6.39e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—KRAS—breast cancer	5.26e-07	6.35e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	5.25e-07	6.33e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTEN—breast cancer	5.2e-07	6.27e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAV1—breast cancer	5.18e-07	6.25e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—KRAS—breast cancer	5.18e-07	6.25e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—KRAS—breast cancer	5.17e-07	6.23e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—breast cancer	5.16e-07	6.23e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—KRAS—breast cancer	5.15e-07	6.21e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—KRAS—breast cancer	5.14e-07	6.19e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HRAS—breast cancer	5.1e-07	6.15e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—KRAS—breast cancer	5.09e-07	6.13e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—NOS3—breast cancer	5.08e-07	6.12e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTEN—breast cancer	5.07e-07	6.12e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—breast cancer	5.07e-07	6.12e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—KRAS—breast cancer	5.07e-07	6.12e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HRAS—breast cancer	5.07e-07	6.11e-06	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—breast cancer	4.99e-07	6.02e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—breast cancer	4.88e-07	5.88e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PIK3CA—breast cancer	4.85e-07	5.85e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HRAS—breast cancer	4.85e-07	5.85e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—breast cancer	4.85e-07	5.85e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PIK3CA—breast cancer	4.84e-07	5.83e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTEN—breast cancer	4.78e-07	5.77e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	4.76e-07	5.74e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PIK3CA—breast cancer	4.75e-07	5.73e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PIK3CA—breast cancer	4.75e-07	5.73e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	4.73e-07	5.71e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CG—breast cancer	4.72e-07	5.69e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	4.72e-07	5.69e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CB—breast cancer	4.69e-07	5.65e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—breast cancer	4.68e-07	5.64e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	4.67e-07	5.63e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	4.66e-07	5.62e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—breast cancer	4.65e-07	5.6e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—breast cancer	4.65e-07	5.6e-06	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—breast cancer	4.61e-07	5.56e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—breast cancer	4.6e-07	5.55e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—breast cancer	4.59e-07	5.54e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—breast cancer	4.58e-07	5.52e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—breast cancer	4.56e-07	5.5e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—breast cancer	4.52e-07	5.45e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—breast cancer	4.51e-07	5.44e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—breast cancer	4.5e-07	5.43e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—breast cancer	4.48e-07	5.4e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HRAS—breast cancer	4.47e-07	5.4e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HRAS—breast cancer	4.4e-07	5.31e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HRAS—breast cancer	4.39e-07	5.3e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HRAS—breast cancer	4.38e-07	5.28e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HRAS—breast cancer	4.37e-07	5.26e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HRAS—breast cancer	4.32e-07	5.21e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HRAS—breast cancer	4.31e-07	5.2e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—breast cancer	4.29e-07	5.17e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—breast cancer	4.28e-07	5.16e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—breast cancer	4.21e-07	5.08e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—breast cancer	4.2e-07	5.07e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—breast cancer	4.19e-07	5.05e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—breast cancer	4.18e-07	5.04e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CD—breast cancer	4.15e-07	5.01e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—breast cancer	4.14e-07	4.99e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—breast cancer	4.13e-07	4.98e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—breast cancer	4.1e-07	4.94e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTEN—breast cancer	4.05e-07	4.89e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—breast cancer	3.97e-07	4.78e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—breast cancer	3.95e-07	4.76e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NOS3—breast cancer	3.92e-07	4.73e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—breast cancer	3.89e-07	4.69e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—breast cancer	3.88e-07	4.68e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—breast cancer	3.88e-07	4.68e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—breast cancer	3.87e-07	4.66e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—breast cancer	3.85e-07	4.65e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—breast cancer	3.82e-07	4.6e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—breast cancer	3.81e-07	4.59e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CA—breast cancer	3.67e-07	4.42e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CB—breast cancer	3.62e-07	4.36e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—breast cancer	3.59e-07	4.32e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CA—breast cancer	3.58e-07	4.32e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CA—breast cancer	3.37e-07	4.07e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTEN—breast cancer	3.13e-07	3.77e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—breast cancer	3e-07	3.61e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—breast cancer	2.92e-07	3.53e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CA—breast cancer	2.86e-07	3.45e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—breast cancer	2.76e-07	3.32e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—breast cancer	2.33e-07	2.82e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CA—breast cancer	2.21e-07	2.66e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—breast cancer	1.8e-07	2.17e-06	CbGpPWpGaD
